Issue area - Drug Policy Archives - Kaiser Permanente Institute for Health Policy

Building Racial Equity into the Drug Development System: Clinical Trials, Access, and Affordability

March 1, 2021
Drug Policy, Drug Policy - Fostering Competitive Markets, Drug Policy - High-Value Therapies for Patients, Health Equity

This webinar is the second in a two-part series that looks at racial equity in the drug development system, from investment all the way through access. This forum will focus on equity in the patent system, clinical trials, healthcare delivery, and affordability.

Building Racial Equity into the Drug Development System

December 7, 2020
Digital Health, Drug Policy, Drug Policy - High-Value Therapies for Patients, Health Equity

Kaiser Permanente’s Institute for Health Policy invites you to join a two-part virtual forum examining racial equity in the drug development system, from research all the way through to access. This first conversation on December 7 will specifically explore racial inequities in drug investment and research and identify new directions for the future.